Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06494488 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Differential Thrombogenesis by EPA and DHA Mediated by HDL

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Aug 1, 2026 to Aug 1, 2027
    • Start date changed from estimate of Feb 1, 2025 to Jul 10, 2025
    • Study sites: 0 to 1
    v3
  2. Start date: Aug 1, 2024 to Feb 1, 2025v2 Show 5 more changesShow less
    • Primary endpoint revised
    • Secondary endpoints: 1 to 8
    • Study description expanded, about 200 words
    • Collaborators: 1 to 2
    • Study title shortened, about 7 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to learn more about omega-3 polyunsaturated fatty acids supplementation on blood lipid profile and platelets in patients with high cholesterol levels. The purpose of this research is to gather information on the safety and effect of two different fish oils, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Participants will: Visit the clinic 3 times during study checkups, tests and blood collection. Randomized to either the EPA or the DHA supplementation group. Be given a 28-day food and activity log.
Trial Details
NCT Number NCT06494488
Lead Sponsor The Miriam Hospital
Collaborators: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Lipid Metabolism Disorders, Hypertriglyceridemia
Related terms Hypertriglyceridemia, Lipid Metabolism Disorders
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov